Objective: To test whether ascorbic acid supplementation has any cytoprotective effect on a model of secondary biliary cirrhosis in young rats.
Introduction
Great interest in the cholestasis syndrome has been awaken due to the frequency of its incidence, both in clinical practice with children and with adults, and due to the large variety of causes identified up to the present moment. [1] [2] [3] In newborns and infants, the incidence is as much as 1 in 500 live births. 4 Some diseases which cause cholestasis in newborns and infants evolve to chronic hepatic disease with biliary cirrhosis, evolving faster than cholestatic diseases in adults. 5 Biliary atresia is the most important cause initiating cholestasis in the first four months of life, as it always evolves to death if untreated and is a principal indication for liver transplant in infancy. 3, 6 Ligature and common biliary duct resection in adult rats has been used as a model for obstructive cholestasis and secondary biliary cirrhosis. However, the execution of these pro- No conflicts of interest declared concerning the publication of this article.
Suggested citation: Passoni CR, Coelho CA. Ascorbic acid supplementation has a cytoprotective effect on secondary biliary cirrhosis: experimental study in young rats. J Pediatr (Rio J Oxidative stress is an intermediary mechanism in the production of the hepatic lesions of cholestasis. 11, 12 Considering that cholestasis leads to malabsorption of liposoluble vitamins, two of which (vitamin A and E) present antioxidant action, this malabsorption aggravates oxidative stress, thus increasing hepatic lesions. 13 We should also consider that ascorbic acid has important physiological functions, such as action over the P450 cytochrome and antioxidant, and that ascorbic acid is hydrosoluble 14, 15 and easily absorbable in cholestasis. 16 We proposed the study of a possible hepatoprotective effect of ascorbic acid supplementation in the biliary cirrhosis model by ligature and resection of the common bile duct (LRCBD) in young rats.
Methods

Experiment design
In order to test the principal hypothesis, we formulated auxiliary hypotheses: SA group: sham operation on P21 and euthanasia on P49.
Daily administration of an aqueous solution of aqueous vehicle, by gavage, at the same volume stipulated for previous groups.
Execution of the experiment
The experimental procedure was approved by the Ethics 
Studies carried out after euthanasia
The serum activity of AST and ALT were determined by the optimized ultraviolet (UV) ray absorption method and 
Statistical analysis
Calculations were executed using the Microsoft Excel 
Discussion
Cholestasis prolonged PST, though in part, and ascorbic acid attenuated this effect of cholestasis ( Figure 1 and Table   1 ). PST has been used to evaluate the functional efficiency of hepatic cells in many experimental models, including cholestatic disease of the liver and hepatic lesions by other mechanisms. [19] [20] [21] A deficiency in ascorbic acid may lead to a decrease in hepatic P450 cytochrome and, thus, affect the hepatic activity of enzymatic drug metabolization. 14 Hepatocytic lesions in cholestasis induced by the ligature of the bile duct may lead to a decrease in the P450 cytochrome isoenzymes. 22 The results shown here suggest that ascorbic acid supplementation stimulates the P450 cytochrome or maintains its function by protecting hepatocytes. Cholestasis increased the serum levels of AST and ALT, independently of the effect of ascorbic acid, and ascorbic acid did not interfere in this effect of cholestasis. Therefore, probably there was no effect on the velocity of hepatocytic necrosis ( Figure 1 and Table 1 ).
Cholestasis reduced the serum levels of albumin, independently of the effect of ascorbic acid, and ascorbic acid did not interfere in this effect of cholestasis ( Figure 2 and Table 1 ).
Thus, ascorbic acid seems not to interfere in the mechanisms of hypoalbuminemia in cholestasis: increased capillary permeability; increased plasmatic volume; lack of compensatory albumin synthesis; reduced hepatocyte mass or lack of elements for albumin synthesis, resulting from secondary mal-nutrition due to the malabsorption present in cholestasis. 19 Cholestasis increased the serum levels of globulin (independently of the effect of ascorbic acid), and ascorbic acid attenuated this effect ( Figure 2 and Table 1 ). This effect probably occurs over immunoglobulins, which are a part of the globulins. Keraan et al. 23 showed that in rats with a portacaval shunt an increase in globulins occurs at the expense of immunoglobulins. This increase is most likely caused by the passage of endotoxins directly to the systemic circulation due to an increase in intrahepatic portal circulation resistance, diverting them from the liver, and thus, reducing the depuration of antigens and immunocomplexes by the liver. This increase in antigens in the systemic circulation would increase immunoglobulin production by the B lymphocytes of the peripherical immune system. 24 Other possible antigens are released by the destruction of hepatocytes. 25, 26 Ascorbic acid could interfere with one or more of these factors which cause hyperglobulinemia.
It was not possible to demonstrate the effect of cholestasis, nor of ascorbic acid, on liver wet weight ( Figure 3 and Table   1 ); ductal hyperplasia and fibrosis may compensate for the reduction in hepatocytes in the phase in which these rats were studied.
Cholestasis increased the liver water content, independently of the effect of ascorbic acid, a fact which could reflect an intracellular water increase ( Figure 3 and Ascorbic acid supplementation could be of significant use in the treatment of children with cholestatic chronic hepatic disease.
